Literature DB >> 11570846

Expression and characterization of recombinant human antithrombin III in Pichia pastoris.

S Mochizuki1, N Hamato, M Hirose, K Miyano, W Ohtani, S Kameyama, S Kuwae, T Tokuyama, H Ohi.   

Abstract

Antithrombin III (ATIII) is a member of the serpin superfamily and a major regulator of the blood coagulation cascade. To express recombinant human ATIII (rATIII) in the methylotrophic yeast Pichia pastoris, we constructed an rATIII expression plasmid which contained the ATIII cDNA encoding mature protein region connected with the truncated mAOX2 promoter and the SUC2 secretion signal, introduced it into the P. pastoris genome, and screened for a single copy transformant. The secretion of rATIII from the transformant reached a level of 320 IU/L in the culture broth at 169 h. From the culture-supernatant, rATIII was purified to over 99% by heparin-affinity chromatography and other column chromatography methods. We characterized rATIII and compared it with human plasma-derived ATIII (pATIII). The purified rATIII possessed correct N-terminal amino acid sequence, and its molecular weight by SDS-PAGE of 56,000 Da was slightly different from the 58,000 Da of pATIII. Sequence and mass spectrometry analysis of BrCN fragments revealed that posttranslational modifications had occurred in rATIII. O-linked mannosylation was found at Ser 3 and Thr 9, and in some rATIII molecules, modification with O-linked mannosyl-mannose had probably occurred at Thr 386, close to the reactive center. Although the heparin-binding affinity of rATIII was 10-fold higher than that of pATIII, its inhibitory activity against thrombin was only half. As the conformation of rATIII and pATIII by circular dichroism spectroscopy was similar, O-glycosylation in the reactive center loop was assumed to be mainly responsible for the decreased inhibitory activity. pATIII can inactivate thrombin through formation of a stable thrombin-ATIII complex, but rATIII modified with O-glycosylation in the reactive center loop may act as a substrate rather than an inhibitor of thrombin. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570846     DOI: 10.1006/prep.2001.1479

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Authors:  Birgitte Giersing; Kazutoyo Miura; Richard Shimp; Jin Wang; Hong Zhou; Andrew Orcutt; Anthony Stowers; Allan Saul; Louis H Miller; Carole Long; Sanjay Singh
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Recent advances on the GAP promoter derived expression system of Pichia pastoris.

Authors:  Ai-Lian Zhang; Jin-Xian Luo; Tian-Yuan Zhang; Ying-Wen Pan; Yan-Hua Tan; Ce-Yi Fu; Fa-zhi Tu
Journal:  Mol Biol Rep       Date:  2008-09-10       Impact factor: 2.316

3.  Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model.

Authors:  Hai Yang; Qing-Wang Li; Zeng-Sheng Han; Jian-Hong Hu; Wen-Ye Li; Zhi-Bin Liu
Journal:  J Thromb Thrombolysis       Date:  2009-05-20       Impact factor: 2.300

4.  A novel serpin with antithrombin-like activity in Branchiostoma japonicum: implications for the presence of a primitive coagulation system.

Authors:  Yeqing Chao; Chunxin Fan; Yujun Liang; Bei Gao; Shicui Zhang
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

5.  Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review.

Authors:  Oriol Cos; Ramón Ramón; José Luis Montesinos; Francisco Valero
Journal:  Microb Cell Fact       Date:  2006-04-06       Impact factor: 5.328

6.  Efficient single step chromatographic purification of recombinant human antithrombin (rhAT) from Saccharomyces cerevisiae.

Authors:  Maheswara Reddy Mallu; Sandeep Vemula; Srinivasa Reddy Ronda
Journal:  3 Biotech       Date:  2016-05-17       Impact factor: 2.406

7.  Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.

Authors:  Shengjun Wang; Yongheng Rong; Yaoguang Wang; Decai Kong; Peng George Wang; Min Chen; Yun Kong
Journal:  Microb Cell Fact       Date:  2020-01-13       Impact factor: 5.328

8.  Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides.

Authors:  Tsuyoshi Yamada; Yutaka Kanda; Makoto Takayama; Akitoshi Hashimoto; Tsutomu Sugihara; Ai Satoh-Kubota; Eri Suzuki-Takanami; Keiichi Yano; Shigeru Iida; Mitsuo Satoh
Journal:  Glycobiology       Date:  2016-01-07       Impact factor: 4.313

Review 9.  Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives.

Authors:  Jennifer Dumont; Don Euwart; Baisong Mei; Scott Estes; Rashmi Kshirsagar
Journal:  Crit Rev Biotechnol       Date:  2015-09-18       Impact factor: 8.429

10.  A novel bi-directional promoter system allows tunable recombinant protein production in Pichia pastoris.

Authors:  Vignesh Rajamanickam; Karl Metzger; Christian Schmid; Oliver Spadiut
Journal:  Microb Cell Fact       Date:  2017-09-13       Impact factor: 5.328

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.